CBL481
Anti-Integrin β1 Antibody, clone TDM29
clone TDM29, Chemicon®, from mouse
Synonym(s):
CD29, platelet GPIIa, VLA beta1-chain, fibronectin receptor beta chain
Sign Into View Organizational & Contract Pricing
All Photos(1)
About This Item
UNSPSC Code:
12352203
eCl@ss:
32160702
NACRES:
NA.41
biological source
mouse
Quality Level
antibody form
purified immunoglobulin
antibody product type
primary antibodies
clone
TDM29, monoclonal
species reactivity
human
manufacturer/tradename
Chemicon®
technique(s)
flow cytometry: suitable
immunofluorescence: suitable
immunoprecipitation (IP): suitable
isotype
IgG1
NCBI accession no.
UniProt accession no.
shipped in
wet ice
target post-translational modification
unmodified
Gene Information
human ... ITGB1(3688)
Related Categories
Specificity
The antibody reacts with the integrin beta1 chain which is a membrane glycoprotein (130 kDa) that can complex with the 6 different alpha-chains of the VLA′s. It is also known as VLA beta1-chain and the fibronectin receptor. The antigen is not expressed on erythrocytes and only weakly stains granulocytes.
Antigen distribution:
T cells: 40 ± 10%
CD4+ cells: 40 ± 20%
CD8+ cells: 40 ± 15%
B cells: 20 ± 5%
Antigen distribution:
T cells: 40 ± 10%
CD4+ cells: 40 ± 20%
CD8+ cells: 40 ± 15%
B cells: 20 ± 5%
Immunogen
U937 cells
Application
Anti-Integrin β1 Antibody, clone TDM29 is an antibody against Integrin β1 for use in FC, IF & IP.
Research Category
Cell Structure
Cell Structure
Research Sub Category
Integrins
Integrins
Physical form
Format: Purified
Immunoglobulin purified by Protein A affinity chromatography and presented in PBS containing 1mg/mL BSA and 10mM sodium azide
Storage and Stability
Maintain at 2°-8°C for up to 12 months from date of receipt.
Legal Information
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Not finding the right product?
Try our Product Selector Tool.
WGK
WGK 2
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Melissa M Ledet et al.
Scientific reports, 10(1), 20580-20580 (2020-11-27)
Determining mechanisms that naturally protect species from developing cancer is critical in order to prevent and treat cancer. Here, we describe a novel cancer-suppressing mechanism, via the secretion of bioactive factors by mammary cells, that is present in domesticated mammals
Feikun Yang et al.
Stem cell research, 39, 101489-101489 (2019-07-06)
Cell-based therapeutic strategies afford major potential advantages in the repair of injured tendons. Generation of induced pluripotent stem cells (iPSCs) expands cell sources for "regenerative" therapy. However, its application in tendon repair is still limited and the effects remain unclear.
Triantafyllos Chavakis et al.
Blood, 105(3), 1036-1043 (2004-09-24)
Angiogenesis and inflammation are closely related biologic processes in wound healing and the responses to vascular injury as well as in cardiovascular diseases; however, the molecular connections are poorly defined. In particular, it is yet unclear whether endogenous factors can
Nikola Danev et al.
iScience, 27(2), 108886-108886 (2024-02-06)
Mesenchymal stromal cells (MSCs) have the potential to be used as therapeutics, but their efficacy varies due to cellular heterogeneity, which is not fully understood. After characterizing donor-matched bovine MSC from adipose tissue (AT), bone marrow (BM), and peripheral blood
Ralf Kaiser et al.
Journal of cellular and molecular medicine, 16(10), 2387-2393 (2012-02-23)
Homing of endothelial progenitor cells (EPCs) is crucial for neoangiogenesis, which might be negatively affected by hypoxia. We investigated the influence of hypoxia on fibronectin binding integrins for migration and cell-matrix-adhesion. AMP-activated kinase (AMPK) and integrin-linked kinase (ILK) were examined
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service